EDGAR Filing Documents for 0001144204-18-019600

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001144204-18-019600

Filing Date

2018-04-06

Accepted

2018-04-06 16:03:36

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	tv490490_s3.htm	S-3	767428
2	EXHIBIT 4.1	tv490490_ex4-1.htm	EX-4.1	253754
3	EXHIBIT 4.2	tv490490_ex4-2.htm	EX-4.2	256432
4	EXHIBIT 5.1	tv490490_ex5-1.htm	EX-5.1	28689
5	EXHIBIT 12.1	tv490490_ex12-1.htm	EX-12.1	7146
6	EXHIBIT 23.1	tv490490_ex23-1.htm	EX-23.1	3114
7	EXHIBIT 23.2	tv490490_ex23-2.htm	EX-23.2	3267
8	EXHIBIT 23.3	tv490490_ex23-3.htm	EX-23.3	2986
9	GRAPHIC	tv490490_img1.jpg	GRAPHIC	33439
10	GRAPHIC	tv490490_img2.jpg	GRAPHIC	112633
11	GRAPHIC	tv490490_img3.jpg	GRAPHIC	128419
12	GRAPHIC	tv490490_img4.jpg	GRAPHIC	24836
	Complete submission text file	0001144204-18-019600.txt		1736238

Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087

Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)